iconstar paper   HBV Articles  
Back grey arrow rt.gif
 
 
Pharmacokinetics of ATI-1428, a Novel Ultra-potent Capsid Assembly Modulator
 
 
  International HBV Meeting; September 18-22, 2022; Paris, France
 
Katherine Squires,1 Dana Schneider,1 Romano Di Fabio,2,3 Matteo Iannacone,4,5,6 Leda Ivanova Bencheva,2 Lorena Donnici,7 Raffaele De Francesco,7,8 Luca G. Guidotti,4,6 Douglas Mayers1 1Antios Therapeutics, Doylestown, PA, USA; 2Promidis, Milan, Italy; 3IRBM Science Park, Pomezia, Rome, Italy; 4Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy; 5Experimental Imaging Center, IRCCS San Raffaele Scientific Institute, Milan, Italy; 6Vita-Salute San Raffaele University, Milan, Italy; 7INGM, National Institute of Molecular Genetics “Romeo ed Enrica Invernizzi”, Milan, Italy; 8Department of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Milan, Italy

0925221

0925222

0925223

0925224

0925225

 
 
 
 
  iconpaperstack View Older Articles   Back to Top   www.natap.org